|
This month, Mansfield Bio-Incubator welcomed two new members.
Paliakkara Corporation facilitates the commercialization of biopharmaceutical assets to serve patients and their families. We are dedicated to improving the health by leveraging our expertise and vision.
Endurazymes is building tools to help the next generation of enzyme-driven innovation reach the world faster. Our technology traces back to Los Alamos National Laboratory and peer-reviewed work on thermostable fluorogenic reporter science. EnduraFAST applies that foundation to a practical commercial problem: helping enzyme teams identify candidates that remain folded, stable, and durable under real process stress.
Is Your Website Accessible to Everyone, Including Investors?
Your website is often the first impression investors, business partners, and potential employees have of your company. But is it accessible to everyone?
Website accessibility is becoming increasingly important, particularly for startups and growing life-science companies. An inaccessible website may limit your business opportunities and expose your company to potential legal risks.
Special November Offer for Mansfield Bio-Incubator Members!
Abrys Consulting Services, a business partner of Mansfield Bio-Incubator member BioElite Innovations, is offering a FREE website accessibility audit to BioInc members throughout November.
Abrys specializes in helping life-science companies develop professional, accessible websites that align with Web Content Accessibility Guidelines (WCAG).
Take advantage of this complimentary service to identify potential accessibility issues and improve your website's effectiveness.
To request your FREE website accessibility audit, please contact BioElite Innovations at info@bioeliteinnovations.com.
In addition, BioElite Innovations has entered into a new business partnership with Blotting Innovations Inc., a company specializing in innovative Western blotting technologies.
This partnership will expand BioElite Innovations' existing Western blotting product portfolio and provide researchers with access to an alternative, efficient, and cost-effective approach to protein gel electrophoresis and Western blotting applications.
Henry Lisoukov, Co-Founder and CEO of BioElite Innovations, commented:
"We are excited to welcome Blotting Innovations as our new business partner. Their innovative approach to running protein gels is an excellent addition to our existing Western blotting portfolio and aligns well with BioElite Innovations' mission to bring advanced and innovative technologies to the life science research community.
We see great potential in this partnership and look forward to working together, expanding our market presence, and achieving continued mutual growth and success."
Cameron Zadeh, CEO of Blotting Innovations, commented:
“Partnering with BioElite Innovations gives us a trusted presence in New England, one of the country’s largest life science hubs. Their local relationships and distribution experience will put our high-throughput Western blotting gels in front of far more researchers, and we’re glad to have them on board.”
About BioElite Innovations
BioElite Innovations, LLC is a privately held life science distribution company founded by experienced executives with extensive expertise in research and development, equipment manufacturing, life science product distribution, vendor management, and warehousing.
The company serves biotechnology, biopharmaceutical, academic, healthcare, and other research organizations by providing high-quality laboratory instruments, research materials, consumables, and innovative technologies.
Through specialized services and strategic business partnerships, BioElite Innovations helps make advanced life science technologies more accessible and supports scientific discovery and innovation.
Website: www.bioeliteinnovations.com
About Blotting Innovations
Blotting Innovations Inc is a Western blotting technology company founded by scientists seeking to overcome the limitations of traditional protein gel electrophoresis. Its innovative technology was developed through NIH-funded research and supported by peer-reviewed scientific studies.
The company offers innovative precast gels that allow researchers to run up to 96 samples on a single Western blot, reducing the need for multiple gels while maintaining sensitivity and improving reproducibility by analyzing samples and replicates under the same experimental conditions.
Designed to work with existing laboratory equipment, this technology offers researchers a practical and cost-effective alternative to traditional Western blotting workflows and expensive automated systems.
Meet Us at the November 12 Pitch Competition
The CEOs of the three companies are planning to participate as sponsors at the upcoming pitch competition on November 12, 2026. Please stop by at one of the BioElite Innovations sponsorship tables to meet us in person and learn more about the products and services we offer.
BioElite Innovations
241 Francis Ave
Mansfield, MA 02048
General Inquiries: info@bioeliteinnovations.com
Product Inquiries & Orders: sales@bioeliteinnovations.com
🌐 Website: www.bioeliteinnovations.com
🔗 LinkedIn: BioElite Innovations
| 
